What changed
TechCrunch Disrupt 2026 has scheduled “Can We Engineer Nature’s Comeback?”, a fireside chat on using AI, genetics, computational biology and synthetic biology in de-extinction and conservation. Ben Lamm, co-founder and CEO of Colossal Biosciences, will participate at the San Francisco event, scheduled for October 13–15.
Why it matters
The headline development is a public investment conversation, not a scientific breakthrough. No species revival, technical milestone, cost, regulatory approval or conservation outcome has been confirmed.
That distinction matters because AI is already being used to analyze genetic data, model biological systems and accelerate discovery. Putting those tools alongside synthetic biology could attract partners and investors to Colossal, while also forcing researchers to explain what they can measure beyond an arresting idea.
The tension is straightforward: engineered revival could support useful conservation tools, but it could also compete for money and attention with protecting existing ecosystems. My expectation is that near-term interest will center on research, modelling and validation rather than a confirmed return of an extinct species.
If funding and partnerships shift toward de-extinction, conservation organizations may face sharper competition for philanthropic and institutional resources. The meaningful signals will be concrete: new financing or named research partners, a defined species or biological milestone, and conservation funding that says whether it is additional or redirected.
What to watch next
Over the next weeks to six months, watch for commitments involving Colossal that specify resources, a research objective and a named partner. Over six to 12 months, look for a verifiable biological milestone or measured conservation goal, alongside evidence of how funders are treating habitat protection and de-extinction.
Comments
No comments yet.